RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 ,inter alia, to consider and approve 1. The Audited Standalone Financial Results as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter and year ended March 31, 2023 together with the Audit Report. 2. To consider and approve the appointment of Secretarial Auditor of the Company for the financial year 2022-23. 3. To take note on Disclosure of Related Party Transactions on a consolidated basis as required under Regulation 23(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for half year ended March 31, 2023.